Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Vincent Paul Liptak currently holds 22,687 shares of BlossomHill Therapeutics, Inc. (BLSM), valued at approximately $0. This represents their equity stake as General Counsel.
Based on SEC Form 4 filings, Vincent Paul Liptak has been a net buyer of BLSM stock. They have purchased $74.7K and sold $0 worth of shares.
Vincent Paul Liptak's most recent insider trade was on Aug 10, 2026, when they sold 22,687 shares at $0.00 per share.
Vincent Paul Liptak serves as General Counsel at BlossomHill Therapeutics, Inc. (BLSM). They have executed 5 insider transactions totaling $74.7K over their tenure at the company.
Vincent Paul Liptak holds the position of General Counsel at BlossomHill Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Vincent Paul Liptak has shown a buying trading pattern, with $74.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Vincent Paul Liptak was on Aug 7, 2026, when they purchased $39.5K worth of BLSM shares. This transaction involved 2,500 shares at $15.80 per share.
Vincent Paul Liptak currently owns 22,687 shares of BlossomHill Therapeutics, Inc. (BLSM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Vincent Paul Liptak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Vincent Paul Liptak has 5 Form 4 filings on record as an insider at BlossomHill Therapeutics, Inc..
Set alerts for Vincent Paul Liptak and 40,000+ other insiders.